Literature DB >> 11296169

Underestimation of mortality following lung volume reduction surgery resulting from incomplete follow-up.

C W Butler1, M Snyder, D E Wood, J R Curtis, R K Albert, J O Benditt.   

Abstract

STUDY
OBJECTIVES: Incomplete follow-up can bias interpretation of data that are collected in longitudinal studies. We noted that many patients failed to return for follow-up in a study of effect of lung volume reduction surgery (LVRS) on quality of life (QOL). Accordingly, we designed this investigation to determine the reasons patients dropped out, and to assess differences between those who continued in the study (attendees) and those who did not (nonattendees).
DESIGN: Telephone survey.
SUBJECTS: Patients with advanced emphysema who had undergone LVRS and had previously agreed to participate in a longitudinal QOL study.
RESULTS: No differences were found with regard to age, gender, preoperative pulmonary function, or oxygen use between attendees and nonattendees. Long-term mortality in nonattendees (27%) was considerably greater than that seen in attendees (3%, p < 0.05). Distance from the hospital, financial burden, and living out of the region were the most common reasons cited by surviving nonattendees for their failure to return for follow-up.
CONCLUSIONS: Studies reporting the long-term mortality after LVRS can be biased in the direction of underestimating the true value if they are compromised by incomplete follow-up.

Entities:  

Mesh:

Year:  2001        PMID: 11296169     DOI: 10.1378/chest.119.4.1056

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Loss to follow-up in cohort studies: how much is too much?

Authors:  Vicki Kristman; Michael Manno; Pierre Côté
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Changes in arterial oxygenation and self-reported oxygen use after lung volume reduction surgery.

Authors:  Margaret L Snyder; Christopher H Goss; Blazej Neradilek; Nayak L Polissar; Zab Mosenifar; Robert A Wise; Alfred P Fishman; Joshua O Benditt
Journal:  Am J Respir Crit Care Med       Date:  2008-06-05       Impact factor: 21.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.